MarketCap
Facebook
X
TelegramQuarterly report 2022-Q2
added 12-16-2023
Covetrus ROA Ratio 2011-2026 | CVET
Annual ROA Ratio Covetrus
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.58 | -0.54 | -29.18 | 4.61 | 2.89 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.61 | -29.18 | -4.76 |
Quarterly ROA Ratio Covetrus
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.29 | -0.29 | -0.41 | -1.2 | -1.49 | -1.6 | -2.48 | -0.05 | -0.53 | -1.51 | -29.59 | -31.36 | -30.74 | -28.13 | 1.66 | 3.19 | 4.55 | 3.05 | 2.33 | 1.03 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.55 | -31.36 | -5.69 |
ROA Ratio of other stocks in the Health information services industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
7.47 | - | - | $ 27.9 B |  USA |
 |
Computer Programs and Systems
CPSI
|
-10.54 | - | 4.4 % | $ 133 M | USA |
 |
Change Healthcare
CHNG
|
-0.58 | - | - | $ 9.03 B | USA |
 |
Accolade
ACCD
|
-10.65 | - | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
-37.29 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
5.28 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
1.15 | - | - | $ 6.37 B | USA |
 |
Evolent Health
EVH
|
-1.05 | $ 2.74 | 3.6 % | $ 257 M | USA |
 |
HealthStream
HSTM
|
3.92 | $ 20.35 | 2.36 % | $ 618 M | USA |
 |
Progyny
PGNY
|
1.73 | $ 20.83 | -0.71 % | $ 1.79 B | USA |
 |
Health Catalyst
HCAT
|
-8.09 | $ 1.83 | -0.82 % | $ 110 M | USA |
 |
iCAD
ICAD
|
-14.96 | - | - | $ 102 M | USA |
 |
Akerna Corp.
KERN
|
-279.09 | - | - | $ 161 M | USA |
 |
10x Genomics
TXG
|
-26.43 | $ 18.95 | 8.22 % | $ 2.22 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
5.54 | - | -10.39 % | $ 886 M | USA |
 |
HealthEquity
HQY
|
0.83 | $ 73.1 | -0.15 % | $ 6.25 B | USA |
 |
American Well Corporation
AMWL
|
-29.56 | $ 5.58 | 28.87 % | $ 89.5 M | USA |
 |
MTBC
MTBC
|
10.96 | - | -0.58 % | $ 51.7 M | USA |
 |
So-Young International
SY
|
-21.55 | $ 3.28 | -5.07 % | $ 260 M |  China |
 |
GoodRx Holdings
GDRX
|
1.18 | $ 2.19 | 0.69 % | $ 845 M | USA |
 |
Omnicell
OMCL
|
0.59 | $ 36.63 | 1.24 % | $ 1.69 B | USA |
 |
OptimizeRx Corporation
OPRX
|
-9.58 | $ 8.86 | 7.92 % | $ 152 M | USA |
 |
1Life Healthcare
ONEM
|
-9.69 | - | - | $ 3.37 B | USA |
 |
Premier
PINC
|
0.58 | - | - | $ 2.33 B | USA |
 |
Phreesia
PHR
|
-36.96 | $ 12.28 | 3.54 % | $ 670 M | USA |
 |
Zhongchao
ZCMD
|
-2.48 | $ 0.21 | -5.71 % | $ 1.09 M | China |
 |
R1 RCM
RCM
|
6.71 | - | - | $ 3.81 B | USA |
 |
NantHealth
NH
|
-42.48 | - | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
1.48 | - | - | $ 1.6 B | USA |
 |
Schrödinger
SDGR
|
-22.73 | $ 11.43 | 1.06 % | $ 831 M | USA |
 |
Signify Health
SGFY
|
-33.07 | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
-28.55 | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
-28.47 | $ 4.77 | 6.71 % | $ 814 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-38.4 | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
8.89 | $ 174.22 | 1.3 % | $ 28 B | USA |
 |
SCWorx Corp.
WORX
|
-17.91 | $ 0.27 | 7.01 % | $ 394 K | USA |